• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Chem Biol . A dimeric proteomimetic prevents SARS-CoV-2 infection by dimerizing the spike protein

tetano

Editor, Senior Moderator
Nat Chem Biol


. 2022 Jun 2.
doi: 10.1038/s41589-022-01060-0. Online ahead of print.
A dimeric proteomimetic prevents SARS-CoV-2 infection by dimerizing the spike protein


Bhavesh Khatri[SUP] 1 [/SUP], Ishika Pramanick[SUP] #[/SUP][SUP] 1 [/SUP], Sameer Kumar Malladi[SUP] #[/SUP][SUP] 1 [/SUP], Raju S Rajmani[SUP] 1 [/SUP], Sahil Kumar[SUP] 2 [/SUP], Pritha Ghosh[SUP] 1 [/SUP], Nayanika Sengupta[SUP] 1 [/SUP], R Rahisuddin[SUP] 3 [/SUP], Narender Kumar[SUP] 3 [/SUP], S Kumaran[SUP] 3 [/SUP], Rajesh P Ringe[SUP] 2 [/SUP], Raghavan Varadarajan[SUP] 1 [/SUP], Somnath Dutta[SUP] 4 [/SUP], Jayanta Chatterjee[SUP] 5 [/SUP]



Affiliations

Abstract

Protein tertiary structure mimetics are valuable tools to target large protein-protein interaction interfaces. Here, we demonstrate a strategy for designing dimeric helix-hairpin motifs from a previously reported three-helix-bundle miniprotein that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Through truncation of the third helix and optimization of the interhelical loop residues of the miniprotein, we developed a thermostable dimeric helix-hairpin. The dimeric four-helix bundle competes with the human angiotensin-converting enzyme 2 (ACE2) in binding to RBD with 2:2 stoichiometry. Cryogenic-electron microscopy revealed the formation of dimeric spike ectodomain trimer by the four-helix bundle, where all the three RBDs from either spike protein are attached head-to-head in an open conformation, revealing a novel mechanism for virus neutralization. The proteomimetic protects hamsters from high dose viral challenge with replicative SARS-CoV-2 viruses, demonstrating the promise of this class of peptides that inhibit protein-protein interaction through target dimerization.
 
Back
Top Bottom